- Home
- OSCR vs IOVA Comparison
OSCR vs IOVA Comparison
Compare OSCR & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSCR
- IOVA
- Stock Information
- Founded
- OSCR 2012
- IOVA 2007
- Country
- OSCR United States
- IOVA United States
- Employees
- OSCR N/A
- IOVA N/A
- Industry
- OSCR Accident &Health Insurance
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OSCR Finance
- IOVA Health Care
- Exchange
- OSCR Nasdaq
- IOVA Nasdaq
- Market Cap
- OSCR 3.3B
- IOVA 2.6B
- IPO Year
- OSCR 2021
- IOVA N/A
- Fundamental
- Price
- OSCR $14.94
- IOVA $5.89
- Analyst Decision
- OSCR Hold
- IOVA Strong Buy
- Analyst Count
- OSCR 8
- IOVA 9
- Target Price
- OSCR $21.56
- IOVA $23.33
- AVG Volume (30 Days)
- OSCR 3.6M
- IOVA 8.2M
- Earning Date
- OSCR 02-04-2025
- IOVA 02-26-2025
- Dividend Yield
- OSCR N/A
- IOVA N/A
- EPS Growth
- OSCR N/A
- IOVA N/A
- EPS
- OSCR 0.12
- IOVA N/A
- Revenue
- OSCR $8,215,224,000.00
- IOVA $90,858,000.00
- Revenue This Year
- OSCR N/A
- IOVA $13,758.71
- Revenue Next Year
- OSCR $23.92
- IOVA $171.20
- P/E Ratio
- OSCR $121.33
- IOVA N/A
- Revenue Growth
- OSCR 51.10
- IOVA 12751.20
- 52 Week Low
- OSCR $10.45
- IOVA $5.77
- 52 Week High
- OSCR $23.79
- IOVA $18.33
- Technical
- Relative Strength Index (RSI)
- OSCR 52.45
- IOVA 26.25
- Support Level
- OSCR $13.89
- IOVA $5.77
- Resistance Level
- OSCR $15.77
- IOVA $8.15
- Average True Range (ATR)
- OSCR 0.88
- IOVA 0.44
- MACD
- OSCR 0.19
- IOVA -0.11
- Stochastic Oscillator
- OSCR 69.49
- IOVA 5.04
About OSCR Oscar Health Inc.
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.